Gene Therapy for Heart Failure Demonstrates Safety and Efficacy in Phase 1 Trial
October 21, 2025
October 21, 2025
BOSTON, Massachusetts, Oct. 21 [Category: BizHospital] -- Mass General Brigham issued the following news release:
* * *
Gene Therapy for Heart Failure Demonstrates Safety and Efficacy in Phase 1 Trial
*
A phase 2 trial is being conducted after findings showed safety of the gene therapy product and stabilization or improvement in severity of patients' condition at 12 months post-treatment.
Phase 1 data for a new gene therapy h . . .
* * *
Gene Therapy for Heart Failure Demonstrates Safety and Efficacy in Phase 1 Trial
*
A phase 2 trial is being conducted after findings showed safety of the gene therapy product and stabilization or improvement in severity of patients' condition at 12 months post-treatment.
Phase 1 data for a new gene therapy h . . .